Human vasoactive hormone adrenomedullin and its binding protein rescue experimental animals from shock

Peptides

Volumn 29, Issue 7, 2008, Pages 1223-1230

  Wu, Rongqian ^a,b   Dong, Weifeng ^a   Qiang, Xiaoling ^a,b   Ji, Youxin ^a   Cui, Tianpen ^a   Yang, Juntao ^a   Zhou, Mian ^a,b   Blau, Steven ^a   Marini, Corrado P ^a   Ravikumar, Thanjavur S ^a,b   Wang, Ping ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Adrenomedullin; Adrenomedullin binding protein 1; Hemorrhage; Survival

Indexed keywords

ADRENOMEDULLIN; AMINOTRANSFERASE; CREATININE; CYTOKINE; INTERLEUKIN 6; LACTIC ACID; PROTEIN AMBP 1; PROTEIN DERIVATIVE; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG HALF LIFE; EXPERIMENTAL STUDY; HEMORRHAGIC SHOCK; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; RAT; RESUSCITATION; SURVIVAL; TISSUE INJURY;

ADRENOMEDULLIN; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; COMPLEMENT FACTOR H; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; HALF-LIFE; HUMANS; LACTIC ACID; MALE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SHOCK, HEMORRHAGIC; SURVIVAL ANALYSIS; TIME FACTORS; VASODILATOR AGENTS;

ANIMALIA; RATTUS;

EID: 44649201047     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.02.021     Document Type: Article

References (42)

1. Anderson R.N., and Smith B.L. Deaths: leading causes for 2001. Natl Vital Stat Rep 52 (2003) 1-85
2. Ayala A., Wang P., Ba Z.F., Perrin M.M., Ertel W., and Chaudry I.H. Differential alterations in plasma IL-6 and TNF levels following trauma and hemorrhage. Am J Physiol 260 (1991) R167-R171
3. Beltowski J., and Jamroz A. Adrenomedullin what we know 10 years since its discovery?. Pol J Pharmacol 56 (2004) 5-27
4. bou-Khalil B., Scalea T.M., Trooskin S.Z., Henry S.M., and Hitchcock R. Hemodynamic responses to shock in young trauma patients: need for invasive monitoring. Crit Care Med 22 (1994) 633-639
5. Cejudo-Martin P., Morales-Ruiz M., Ros J., Navasa M., Fernandez-Varo G., Fuster J., et al. Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients. Hepatology 36 (2002) 1172-1179
6. Cui X., Wu R., Zhou M., Dong W., Ulloa L., Yang H., et al. Adrenomedullin and its binding protein attenuate the proinflammatory response after hemorrhage. Crit Care Med 33 (2005) 391-398
7. Dackor R., and Caron K. Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock. Peptides 28 (2007) 2164-2170
8. Deitch E.A., and Dayal S.D. Intensive care unit management of the trauma patient. Crit Care Med 34 (2006) 2294-2301
9. Dogan A., Suzuki Y., Koketsu N., Osuka K., Saito K., Takayasu M., et al. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 17 (1997) 19-25
10. Ehlenz K., Koch B., Preuss P., Simon B., Koop I., and Lang R.E. High levels of circulating adrenomedullin in severe illness: correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol Diabetes 105 (1997) 156-162
11. Elsasser T.H., Kahl S., Martinez A., Montuenga L.M., Pio R., and Cuttitta F. Adrenomedullin binding protein in the plasma of multiple species: characterization by radioligand blotting. Endocrinol 140 (1999) 4908-4911
12. Friese M.A., Hellwage J., Jokiranta T.S., Meri S., Muller-Quernheim H.J., Peter H.H., et al. Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA). Clin Exp Immunol 121 (2000) 406-415
13. Friese M.A., Hellwage J., Jokiranta T.S., Meri S., Peter H.H., Eibel H., et al. FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol Immunol 36 (1999) 809-818
14. Fujioka S. Increased plasma concentration of adrenomedullin during and after major surgery. Surg Today 31 (2001) 575-579
15. Fujioka S., Ono Y., Kangawa K., and Okada K. Plasma concentration of adrenomedullin is increased in hemorrhagic shock in dogs. Anesth Analg 88 (1999) 326-328
16. Isumi Y., Kubo A., Katafuchi T., Kangawa K., and Minamino N. Adrenomedullin suppresses interleukin-1β-induced tumor necrosis factor-α production in Swiss 3T3 cells. FEBS Lett 463 (1999) 110-114
17. Kikumoto K., Kubo A., Hayashi Y., Minamino N., Inoue S., Dohi K., et al. Increased plasma concentration of adrenomedullin in patients with subarachnoid hemorrhage. Anesth Analg 87 (1998) 859-863
18. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192 (1993) 553-560
19. Kubo A., Minamino N., Isumi Y., Katafuchi T., Kangawa K., Dohi K., et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 273 (1998) 16730-16738
20. Luo W., and Vik D.P. Regulation of complement factor H in a human liver cell line by interferon-gamma. Scand J Immunol 49 (1999) 487-494
21. Miksa M., Wu R., Cui X., Dong W., Das P., Simms H.H., et al. Vasoactive hormone adrenomedullin and its binding protein: anti-inflammatory effects by up-regulating peroxisome proliferator-activated receptor-gamma. J Immunol 179 (2007) 6263-6272
22. Miyao Y., Nishikimi T., Goto Y., Miyazaki S., Daikoku S., Morii I., et al. Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart 79 (1998) 39-44
23. Moore F.A., McKinley B.A., and Moore E.E. The next generation in shock resuscitation. Lancet 363 (2004) 1988-1996
24. Nagata D., Hirata Y., Suzuki E., Kakoki M., Hayakawa H., Goto A., et al. Hypoxia-induced adrenomedullin production in the kidney. Kidney Int 55 (1999) 1259-1267
25. Nagaya N., Nishikimi T., Uematsu M., Yoshitomi Y., Miyao Y., Miyazaki S., et al. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction. Heart 81 (1999) 483-487
26. Nishio K., Akai Y., Murao Y., Doi N., Ueda S., Tabuse H., et al. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 25 (1997) 953-957
27. Peitzman A.B., Billiar T.R., Harbrecht B.G., Kelly E., Udekwu A.O., and Simmons R.C. Hemorrhagic shock. Curr Probl Surg 32 (1995) 925-1002
28. Pio R., Martinez A., Unsworth E.J., Kowalak J.A., Bengoechea J.A., Zipfel P.F., et al. Complement factor H is a serum binding protein for adrenomedullin: the resulting complex modulates the bioactivities of both partners. J Biol Chem 276 (2001) 12292-12300
29. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Matsuo H., et al. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 195 (1993) 921-927
30. Samson W.K. Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 61 (1999) 363-389
31. Scalea T.M., Maltz S., Yelon J., Trooskin S.Z., Duncan A.O., and Sclafani S.J. Resuscitation of multiple trauma and head injury: role of crystalloid fluids and inotropes. Crit Care Med 22 (1994) 1610-1615
32. Schwaeble W., Zwirner J., Schulz T.F., Linke R.P., Dierich M.P., and Weiss E.H. Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur J Immunol 17 (1987) 1485-1489
33. Szebeni J., Baranyi L., Savay S., Gotze O., Alving C.R., Bunger R., et al. Complement activation during hemorrhagic shock and resuscitation in swine. Shock 20 (2003) 347-355
34. Ueda S., Nishio K., Minamino N., Kubo A., Akai Y., Kangawa K., et al. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 160 (1999) 132-136
35. Wu R., Cui X., Dong W., Zhou M., Simms H.H., and Wang P. Mechanisms responsible for vascular hyporesponsiveness to adrenomedullin after hemorrhage: the central role of adrenomedullin binding protein-1. Ann Surg 242 (2005) 115-123
36. Wu R., Dong W., Zhou M., Cui X., Simms H.H., and Wang P. A novel approach to maintaining cardiovascular stability after hemorrhagic shock: beneficial effects of adrenomedullin and its binding protein. Surgery 137 (2005) 200-208
37. Wu R., Dong W., Zhou M., Simms H.H., Marini C.P., Ravikumar T.S., et al. Adrenomedullin and adrenomedullin binding protein-1 prevent metabolic acidosis after uncontrolled hemorrhage in rats. Crit Care Med 35 (2007) 912-918
38. Wu R., and Wang P. Preclinical studies with adrenomedullin and its binding protein as cardiovascular protective agents for hemorrhagic shock. Cardiovasc Drug Rev 24 (2006) 204-213
39. Wu R., Zhou M., Cui X., Simms H.H., and Wang P. Ghrelin clearance is reduced at the late stage of polymicrobial sepsis. Int J Mol Med 12 (2003) 777-781
40. Wu R., Zhou M., and Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul Pept 112 (2003) 19-26
41. Yang S., Hu S., Choudhry M.A., Rue III L.W., Bland K.I., and Chaudry I.H. Anti-rat soluble IL-6 receptor antibody down-regulates cardiac IL-6 and improves cardiac function following trauma-hemorrhage. J Mol Cell Cardiol 42 (2007) 620-630
42. Zhou M., Ba Z.F., Chaudry I.H., and Wang P. Adrenomedullin binding protein-1 modulates vascular responsiveness to adrenomedullin in late sepsis. Am J Physiol Regul Integr Comp Physiol 283 (2002) R553-R560